Abstract
Objectives
To compare the efficacy of ethanol ablation (EA) of cystic and predominantly cystic thyroid nodules, and to evaluate factors affecting efficacy.
Methods
From October 2008 to December 2010, a total of 217 thyroid nodules were treated with EA. Nodule volumes, symptoms and cosmetic scores were evaluated before and after EA. EA efficacy in treating cystic and predominantly cystic nodules was compared; and factors related to EA efficacy in each type, including initial volume, solid component, vascularity, fluid nature, ethanol retention time and number of EA sessions, were evaluated.
Results
Mean nodule volume decreased from 15.7 ± 18.1 ml to 3.0 ± 7.9 ml (mean volume reduction, 85.2 ± 16.1%) and the therapeutic success rate was 90.3% at last follow-up. EA was significantly more effective in cystic than predominantly cystic nodules. Independent predictors of EA efficacy for all nodules included initial volume, solid component and vascularity. Initial volume and vascularity were independent predictors of EA efficacy in predominantly cystic nodules, but no factor was independently related to efficacy in cystic nodules.
Conclusions
EA is effective in both cystic and predominantly cystic nodules, especially the former. EA is less effective in large or vascular predominantly cystic nodules, but is effective in cystic nodules regardless of related factors.
Key Points
• Ethanol ablation under ultrasound guidance is increasingly used for cystic thyroid nodules.
• EA seems effective for cystic and predominantly cystic nodules, especially cystic nodules.
• The effectiveness of EA was reduced in large or vascular predominantly cystic nodules.
Similar content being viewed by others
References
Bennedbaek FN, Hegedus L (2003) Treatment of recurrent thyroid cysts with ethanol: a randomized double-blind controlled trial. J Clin Endocrinol Metab 88:5773–5777
Del Prete S, Caraglia M, Russo D et al (2002) Percutaneous ethanol injection efficacy in the treatment of large symptomatic thyroid cystic nodules: ten-year follow-up of a large series. Thyroid 12:815–821
Mazzaferri EL (1999) An overview of the management of papillary and follicular thyroid carcinoma. Thyroid 9:421–427
Sarda AK, Bal S, Dutta Gupta S, Kapur MM (1988) Diagnosis and treatment of cystic disease of the thyroid by aspiration. Surgery 103:593–596
Smith MD, Serpell JW, Morgan JL, Cheng MS (2003) Fine needle aspiration in the management of benign thyroid cysts. ANZ J Surg 73:477–479
Cho YS, Lee HK, Ahn IM et al (2000) Sonographically guided ethanol sclerotherapy for benign thyroid cysts: results in 22 patients. AJR Am J Roentgenol 174:213–216
Kim JH, Lee HK, Lee JH, Ahn IM, Choi CG (2003) Efficacy of sonographically guided percutaneous ethanol injection for treatment of thyroid cysts versus solid thyroid nodules. AJR Am J Roentgenol 180:1723–1726
Monzani F, Lippi F, Goletti O et al (1994) Percutaneous aspiration and ethanol sclerotherapy for thyroid cysts. J Clin Endocrinol Metab 78:800–802
Zingrillo M, Torlontano M, Chiarella R et al (1999) Percutaneous ethanol injection may be a definitive treatment for symptomatic thyroid cystic nodules not treatable by surgery: five-year follow-up study. Thyroid 9:763–767
Zingrillo M, Torlontano M, Ghiggi MR et al (1996) Percutaneous ethanol injection of large thyroid cystic nodules. Thyroid 6:403–408
Kim DW, Rho MH, Kim HJ, Kwon JS, Sung YS, Lee SW (2005) Percutaneous ethanol injection for benign cystic thyroid nodules: is aspiration of ethanol-mixed fluid advantageous? AJNR Am J Neuroradiol 26:2122–2127
Yasuda K, Ozaki O, Sugino K et al (1992) Treatment of cystic lesions of the thyroid by ethanol instillation. World J Surg 16:958–961
Jang SW, Baek JH, Kim JK et al (2011) How to manage the patients with unsatisfactory results after ethanol ablation for thyroid nodules: role of radiofrequency ablation. Eur J Radiol. doi:10.1016/j.ejrad.2011.02.039
Lee JH, Kim YS, Lee D, Choi H, Yoo H, Baek JH (2010) Radiofrequency ablation (RFA) of benign thyroid nodules in patients with incompletely resolved clinical problems after ethanol ablation (EA). World J Surg 34:1488–1493
Moon WJ, Baek JH, Jung SL et al (2011) Ultrasonography and the ultrasound-based management of thyroid nodules: consensus statement and recommendations. Korean J Radiol 12:1–14
Moon WJ, Jung SL, Lee JH et al (2008) Benign and malignant thyroid nodules: US differentiation—multicenter retrospective study. Radiology 247:762–770
Ha EJ, Baek JH, Lee JH (2011) The efficacy and complications of radiofrequency ablation of thyroid nodules. Curr Opin Endocrinol Diabetes Obes 18:310–314
Jeong WK, Baek JH, Rhim H et al (2008) Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Eur Radiol 18:1244–1250
Baek JH, Kim YS, Sung JY, Choi H, Lee JH (2011) Locoregional control of metastatic well-differentiated thyroid cancer by ultrasound-guided radiofrequency ablation. AJR Am J Roentgenol 197:W331–W336
Kim SM, Baek JH, Kim YS et al (2010) Efficacy and safety of ethanol ablation for thyroglossal duct cysts. AJNR Am J Neuroradiol 32:306–309
Sung JY, Baek JH, Kim YS et al (2008) One-step ethanol ablation of viscous cystic thyroid nodules. AJR Am J Roentgenol 191:1730–1733
Sung JY, Kim YS, Choi H, Lee JH, Baek JH (2011) Optimum first-line treatment technique for benign cystic thyroid nodules: ethanol ablation or radiofrequency ablation? AJR Am J Roentgenol 196:W210–W214
Baek JH, Lee JH, Valcavi R, Pacella CM, Rhim H, Na DG (2011) Thermal ablation for benign thyroid nodules: radiofrequency and laser. Korean J Radiol 12:525–540
Baek JH, Kim YS, Lee D, Huh JY, Lee JH (2010) Benign predominantly solid thyroid nodules: prospective study of efficacy of sonographically guided radiofrequency ablation versus control condition. AJR Am J Roentgenol 194:1137–1142
Baek JH, Moon WJ, Kim YS, Lee JH, Lee D (2009) Radiofrequency ablation for the treatment of autonomously functioning thyroid nodules. World J Surg 33:1971–1977
Park NH, Kim DW, Park HJ et al (2011) Thyroid cysts treated with ethanol ablation can mimic malignancy during sonographic follow-up. J Clin Ultrasound 39:441–446
Valcavi R, Frasoldati A (2004) Ultrasound-guided percutaneous ethanol injection therapy in thyroid cystic nodules. Endocr Pract 10:269–275
Zingrillo M, Ghiggi MR, Liuzzi A (1996) A large, nonfunctioning parathyroid cyst recurring after aspiration and subsequently cured by percutaneous ethanol injection. J Clin Ultrasound 24:378–382
Lee SJ, Ahn IM (2005) Effectiveness of percutaneous ethanol injection therapy in benign nodular and cystic thyroid diseases: long-term follow-up experience. Endocr J 52:455–462
Bennedbaek FN, Nielsen LK, Hegedus L (1998) Effect of percutaneous ethanol injection therapy versus suppressive doses of L-thyroxine on benign solitary solid cold thyroid nodules: a randomized trial. J Clin Endocrinol Metab 83:830–835
Caraccio N, Goletti O, Lippolis PV (1997) Is percutaneous ethanol injection a useful alternative for the treatment of the cold benign thyroid nodule? Five years’ experience. Thyroid 7:699–704
Bennedbaek FN, Karstrup S, Hegedus L (1997) Percutaneous ethanol injection therapy in the treatment of thyroid and parathyroid diseases. Eur J Endocrinol 136:240–250
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, Y.J., Baek, J.H., Ha, E.J. et al. Cystic versus predominantly cystic thyroid nodules: efficacy of ethanol ablation and analysis of related factors. Eur Radiol 22, 1573–1578 (2012). https://doi.org/10.1007/s00330-012-2406-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-012-2406-5